ArticleNPJ Parkinson's disease2025

Plasma fibronectin is a prognostic biomarker of disability in Parkinson's disease: a prospective, multicenter cohort study.

Shuzhen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.